Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval HSAI Hesai shares climb 638 percent despite Q4 2025 earnings per share missing analyst forecasts Is Kyndryl Holdings KD stock forming a breakout pattern Q1 2026 EPS Misses Estimates